Menu

• Ask a Health Expert about FAT NECROSIS
• Post Your Side Effect related to FAT NECROSIS
• FAT NECROSIS and FDA Warnings
• FAT NECROSIS in Patients Wiki
• Report FAT NECROSIS in Drug Side Effect Survey

FAT NECROSIS side effect

What is FAT NECROSIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Zemplar Side Effects Report #5656908-2
Physician from GERMANY reported ZEMPLAR problem on Feb 29, 2008. Female patient, weighting 176.4 lb, was diagnosed with renal failure and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: fat necrosis, lipomatosis, sepsis, . ZEMPLAR dosage: unknown. During the same period patient was treated with GLIMEPIRIDE, XIPAMIDE, NEBIVOLOL, MOXONIDINE, DOXAZOSIN MESYLATE, FLUVASTATIN, ESOMEPRAZOLE MAGNESIUM, CALCIUM ACETATE. Patient died.

Rebif Side Effects Report #5632521-8
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2008. Male patient, 58 years of age, was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: fat necrosis, injection site reaction, neutrophilic panniculitis, . REBIF dosage: unknown. During the same period patient was treated with METHOTREXATE, RITUXIMAB. Patient was hospitalized. Patient recovered.

Humira Side Effects Report #5588915-2
Consumer or non-health professional from UNITED STATES reported HUMIRA problem on Jan 02, 2008. Female patient, weighting 160.1 lb, was diagnosed with psoriatic arthropathy and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: fat necrosis, impaired healing, psoriatic arthropathy, sciatica, wound, wound drainage, . HUMIRA dosage: unknown. During the same period patient was treated with ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE. Patient was hospitalized. Patient recovered.

Humira Side Effects Report #5602776-4
HUMIRA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 15, 2008. Female patient, weighting 160.1 lb, was diagnosed with psoriatic arthropathy and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: fat necrosis, impaired healing, psoriatic arthropathy, sciatica, wound, wound drainage, . HUMIRA dosage: unknown. During the same period patient was treated with ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE. Patient was hospitalized. Patient recovered.


Sandostatin Side Effects Report #5751620-3
Consumer or non-health professional from UNITED STATES reported SANDOSTATIN LAR problem on May 20, 2008. Female patient, weighting 103.6 lb, was diagnosed with short-bowel syndrome and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: fat necrosis, injection site atrophy, . SANDOSTATIN LAR dosage: 20 MG,. During the same period patient was treated with IMODIUM, LOMOTIL. Patient recovered.

Rebif Side Effects Report #5392783-1
REBIF problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 05, 2007. Female patient, 24 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: calcinosis, fat necrosis, injection site erythema, injection site macule, subcutaneous nodule, . REBIF dosage: unknown. Patient recovered.

Rebif Side Effects Report #5392783-1
Consumer or non-health professional from UNITED KINGDOM reported REBIF problem on July 05, 2007. Female patient, 24 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: calcinosis, fat necrosis, injection site erythema, injection site macule, subcutaneous nodule, . REBIF dosage: unknown. Patient recovered.

Betaseron Side Effects Report #5298181-3
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2007. Female patient, 44 years of age, weighting 121.3 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: abscess, fat necrosis, injection site discolouration, skin necrosis, . BETASERON dosage: unknown. During the same period patient was treated with NEXIUM, KLONOPIN, DETROL. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5508730-5
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Oct 24, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: breast cancer female, breast cancer in situ, fat necrosis, fibrosis, inflammation, oestrogen receptor assay positive, progesterone receptor assay positive, . AVONEX dosage: unknown. Patient recovered.


Vivitrol Side Effects Report #5421715-2
VIVITROL problem was reported by a Pharmacist from UNITED STATES on Aug 02, 2007. Female patient, weighting 130.0 lb, was diagnosed with alcoholism and was treated with VIVITROL. After drug was administered, patient experienced the following problems/side effects: cellulitis, discomfort, fat necrosis, foreign body trauma, headache, injection site abscess, injection site pruritus, injection site reaction, nausea, . VIVITROL dosage: (380 MG 1X/MONTH INTRAMUSCULAR). During the same period patient was treated with DIOVAN, PREMARIN. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5443446-5
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Aug 22, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: breast cancer female, breast cancer in situ, fat necrosis, oestrogen receptor assay positive, progesterone receptor assay positive, . AVONEX dosage: unknown. Patient recovered.

Hydroxyzine Side Effects Report #5394611-7
HYDROXYZINE problem was reported by a Physician from UNITED STATES on July 09, 2007. Female patient, 45 years of age, was diagnosed with pruritus and was treated with HYDROXYZINE. After drug was administered, patient experienced the following problems/side effects: cellulitis, embolia cutis medicamentosa, fat necrosis, gait disturbance, injection site oedema, injection site pain, muscle haemorrhage, muscle necrosis, myositis, . HYDROXYZINE dosage: 25 MG, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.

Hydroxyzine Side Effects Report #5394611-7
Physician from UNITED STATES reported HYDROXYZINE problem on July 09, 2007. Female patient, 45 years of age, was diagnosed with pruritus and was treated with HYDROXYZINE. After drug was administered, patient experienced the following problems/side effects: cellulitis, embolia cutis medicamentosa, fat necrosis, gait disturbance, injection site oedema, injection site pain, muscle haemorrhage, muscle necrosis, myositis, . HYDROXYZINE dosage: 25 MG, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.

Depakote Side Effects Report #5297774-7
DEPAKOTE ER problem was reported by a Pharmacist from UNITED STATES on Apr 12, 2007. Male patient, weighting 235.0 lb, was diagnosed with bipolar i disorder and was treated with DEPAKOTE ER. After drug was administered, patient experienced the following problems/side effects: constipation, diarrhoea, fat necrosis, pancreatitis haemorrhagic, pancreatitis necrotising, somnolence, . DEPAKOTE ER dosage: 2000 MG DAILY PO. During the same period patient was treated with SEROQUEL, DEPAKOTE ER. Patient died on 12/12/2006.


Diclofenac Side Effects Report #5264153-8
Consumer or non-health professional from reported DICLOFENAC problem on Mar 05, 2007. Female patient, 47 years of age, was diagnosed with back pain and was treated with DICLOFENAC. After drug was administered, patient experienced the following problems/side effects: embolia cutis medicamentosa, erythema, fat necrosis, injection site pain, pallor, scar, skin necrosis, . DICLOFENAC dosage: unknown. Patient recovered.